Google dissolves AI ethics board just 9 days after its creation

Google has dissolved its AI ethics board just a week after it was founded to guide “responsible development of AI” within the company.

Vox first reported the news April 4, nine days after Google announced the creation of its Advanced Technology External Advisory Council (ATEAC), an eight-member board slated to meet four times over the course of 2019 to discuss concerns about Google’s AI program.

Worries arose early on about several board members, including Heritage Foundation president Kay Cole James and drone company CEO Dyan Gibbens. James has come under fire for her comments about transgender people and her organization’s skepticism of climate change, while Gibbens has reopened the debate about using Google’s AI for military applications.

Some 2,300 Google employees signed a petition to remove James from the ATEAC, and Alessandro Acquisti, a privacy researcher and ATEAC board member, announced his resignation four days after Google founded the council. Other board members were pressed to justify their decisions to stay.

“It’s become clear that in the current environment, ATEAC can’t function as we wanted,” Google said in a brief, 53-word statement. “So we’re ending the council and going back to the drawing board. We’ll continue to be responsible in our work on the important issues that AI raises, and will find different ways of getting outside opinions on these topics.”

Read the full report from Vox below:

""

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup